Alfredo Budillon
Alfredo Budillon
Istituto Tumori Napoli G. Pascale
Email verificata su istitutotumori.na.it
TitoloCitata daAnno
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795, 2015
5382015
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, iná…
E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ...
Journal of cellular physiology 195 (1), 139-150, 2003
1692003
cAMP-dependent protein kinase: role in normal and malignant growth
YS Cho-Chung, S Pepe, T Clair, ADO Budillon, M Nesterova
Critical reviews in oncology/hematology 21 (1-3), 33-61, 1995
1651995
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon
Endocrine-related cancer 13 (1), 7-26, 2006
1452006
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine
M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007
1392007
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells
M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ...
Journal of cellular physiology 204 (2), 539-548, 2005
1362005
The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma
A Guerra, MR Sapio, V Marotta, E Campanile, S Rossi, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 517-524, 2012
1312012
Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis
G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ...
The Journal of pathology 202 (3), 305-312, 2004
1292004
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1
D Melisi, Q Xia, G Paradiso, J Ling, T Moccia, C Carbone, A Budillon, ...
Journal of the National Cancer Institute 103 (15), 1190-1204, 2011
1262011
Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients
R Bei, A Budillon, L Masuelli, V Cereda, D Vitolo, E Di Gennaro, ...
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2004
1192004
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ...
Journal of cellular physiology 226 (9), 2378-2390, 2011
1172011
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome
A Guerra, L Fugazzola, V Marotta, M Cirillo, S Rossi, V Cirello, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), 2333-2340, 2012
1162012
New perspective for an old antidiabetic drug: metformin as anticancer agent
A Leone, E Di Gennaro, F Bruzzese, A Avallone, A Budillon
Advances in Nutrition and Cancer, 355-376, 2014
1132014
Acetylation of proteins as novel target for antitumor therapy
E Di Gennaro, F Bruzzese, M Caraglia, A Abruzzese, A Budillon
Amino acids 26 (4), 435-441, 2004
1052004
An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells
H Yokozaki, A Budillon, G Tortora, S Meissner, SL Beaucage, K Miki, ...
Cancer research 53 (4), 868-872, 1993
1041993
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis
M Caraglia, M Marra, G Giuberti, AM D'alessandro, A Budillon, ...
Amino acids 20 (2), 91-104, 2001
1012001
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
M Colone, A Calcabrini, L Toccacieli, G Bozzuto, A Stringaro, M Gentile, ...
Journal of Investigative Dermatology 128 (4), 957-971, 2008
982008
Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation
M Caraglia, A Budillon, G Vitale, G Lupoli, P Tagliaferri, A Abbruzzese
European journal of biochemistry 267 (13), 3919-3936, 2000
952000
The farnesyl transferase inhibitor R115777 (Zarnestra«) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acidá…
M Caraglia, AM D'Alessandro, M Marra, G Giuberti, G Vitale, C Viscomi, ...
Oncogene 23 (41), 6900, 2004
942004
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer
P Tagliaferri, M Caraglia, A Budillon, M Marra, G Vitale, C Viscomi, ...
Cancer Immunology, Immunotherapy 54 (1), 1-10, 2005
932005
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20